Comparison of the efficacy and safety of injectable propafenone and amiodarone for elimination of paroxysmal atrial fibrillation in patients without organic heart disease.
18 March 2019 (08:30 - 18:00)
Organised by:
Abstract
About the speaker
National Research Center for Preventive Medicine, Moscow (Russian Federation)
6 More presentations in this session
Access the full session
The Event
EHRA 2019
18 March 2019
08:30 CET
